AVE Science & Technology
Beijing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A Chinese biotech developing novel vaccines and biologics for infectious diseases.
Infectious DiseaseVaccines
Technology Platform
Utilizes modern vaccine design platforms, potentially including recombinant or nucleic acid-based technologies, for developing prophylactic and therapeutic biologics.
Opportunities
Benefiting from strong Chinese government support for vaccine self-sufficiency and biosecurity.
Risk Factors
High clinical development risk and potential for pipeline delays or failures in a technically challenging field.
Competitive Landscape
Faces intense competition from large state-owned vaccine producers and global pharma giants in a crowded infectious disease space.